Comparison
Hair loss treatments compared: what is proven in humans
13 treatments and procedures for hereditary hair loss: approval, what has been shown on hair and BK-Score at a glance.
6 min read updated November 15, 2026
The short answer
The best evidence is for the two treatments approved in Germany for hereditary hair loss: finasteride and minoxidil. For both, the effect has been counted in blinded trials: they slow hair loss, and additional hair grows back. Dutasteride did even slightly better than finasteride in trials but is not approved for hair loss in Germany. New substances meant to block the hormone signal only at the scalp are in phase 3, with figures so far only from the manufacturers. For biotin with normal intake, saw palmetto, GHK-Cu or exosomes, solid data on scalp hair are lacking (as of 15 November 2026).
All treatments at a glance
| Treatment | Approval | What has been shown on hair | BK-Score |
|---|---|---|---|
| Approved for hair loss in Germany | |||
| Finasteride (Propecia)5-alpha reductase inhibitor | approved in Germany (1 mg tablet, plus a spray), prescription-only | in two blinded trials with 1,553 men, 107 more hairs than placebo after one year and 138 after two (counted area) | Well supported, heavily overhyped Human evidence 9/10 |
| Minoxidil (Regaine)potassium channel opener | solution or foam up to 5 % over the counter in pharmacies; the tablet is approved only for severe high blood pressure | on the scalp shown in blinded trials for decades; for the low-dose tablet one blinded comparison trial and a network meta-analysis | Well supported, heavily overhyped Human evidence 8/10 |
| Approved for something else, used for hair loss off-label | |||
| Dutasteride (Avodart)5-alpha reductase inhibitor (types I and II) | in Germany only for prostate enlargement; approved for hair loss in Japan and South Korea | in blinded 24-week trials more hair than placebo and than finasteride | Supported, with caveats Human evidence 7/10 |
| Ketoconazole shampooantifungal for the skin | 2 % over the counter in pharmacies, approved for seborrhoeic dermatitis, not for hair loss | small studies: in 150 men with hair loss and dandruff, 17.3 % fewer shed hairs over six months | Long used, barely studied Human evidence 3/10 |
| Clascoterone (Winlevi / Breezula)topical androgen receptor blocker | approved as a cream for acne (EU since 2025), not for hair loss | two phase 3 trials with 1,465 men successful according to the manufacturer, hair counts not yet published | Supported, with caveats Human evidence 6/10 |
| Unapproved substances | |||
| Pyrilutamide (KX-826)topical androgen receptor blocker | approved nowhere; application in China announced for 2026 | phase 3 with 666 men: 10.65 more hairs per cm² than placebo after 24 weeks, according to the manufacturer | Thin human evidence Human evidence 5/10 |
| RU58841topical antiandrogen | never approved, sold as a research chemical | only animal and tissue data, for example in macaques; no study of the effect in humans | Not studied in humans Human evidence 1/10 |
| Procedures and devices | |||
| PRP (platelet-rich plasma)medical procedure | medical procedure using your own blood | meta-analysis of 43 randomised trials with 1,877 participants: more hair density, moderate evidence, very inconsistent methods | Studied – no benefit shown Human evidence 5/10 |
| Red light (LED caps)photobiomodulation | some devices cleared for the US market | meta-analyses show more hair density; a large sham-controlled trial with 160 participants missed its primary endpoint | Thin human evidence Human evidence 5/10 |
| Heavily marketed, barely tested on scalp hair | |||
| Saw palmettoplant extract | sold as a supplement and herbal remedy for prostate symptoms | only 5 small randomised trials, often with combination products | Supported, with caveats Human evidence 7/10 |
| Biotinvitamin B7 | freely available | helps in true deficiency; no positive controlled trial with normal intake | Thin human evidence Human evidence 5/10 |
| GHK-Cu (copper peptide)copper tripeptide | freely sold in cosmetics, not approved as a medicine | only one small study on the eyebrows; the often-cited comparison with minoxidil could not be verified | Thin human evidence Human evidence 4/10 |
| Exosomescell vesicles as serum or injection | not approved | 9 clinical studies with 125 patients in total, almost all without a control group | Hype far ahead of evidence Human evidence 2/10 |
How to read the table
- This is about hereditary hair loss. Alopecia areata and hair loss due to iron deficiency, thyroid problems or after an illness have other causes and should be checked by a doctor.
- Slowing down is already a success. Without treatment, hereditary hair loss keeps progressing; in the finasteride trials, loss continued on placebo and was slowed on the drug.
- Manufacturer data are a start. For pyrilutamide and clascoterone, the results so far come from company announcements, not peer-reviewed publications.
- No doses, no sources. For unapproved substances we deliberately give no amounts and link no sellers.
Side effects worth knowing
- Finasteride: sexual dysfunction is known. Since a Dear Healthcare Professional letter of 15 September 2025, suicidal thoughts are also an established side effect of the tablets; with depressed mood, treatment should be stopped and medical advice sought.
- Dutasteride: in the trial in men with hair loss, sexual side effects occurred twice as often as on placebo, 16 versus 8 percent. It must not be used in women, children or adolescents.
- Minoxidil: on the scalp, itching and irritation are most common. With the low-dose tablet, a large analysis found increased body hair most often (15.1 percent), less often dizziness, fluid retention and palpitations; pericardial effusion and fluid retention are known from blood pressure treatment.
- RU58841: after application to the scalp the substance reaches the blood, and breakdown products remain in the body for days. There are no tolerability data from human trials.
When to see a doctor
Sudden, patchy or very heavy hair loss, hair loss in women or hair loss together with other symptoms should be checked by a doctor before reaching for any product. Finasteride, dutasteride and minoxidil tablets are prescription-only and belong in medical hands.
Frequently asked questions
What works best against hereditary hair loss?
The best evidence is for finasteride and minoxidil, which are approved in Germany for hereditary hair loss. Both slow hair loss, and in blinded trials additional hair grows back. Dutasteride worked slightly better in trials but is not approved for hair loss in Germany.
Is RU58841 an alternative to finasteride?
Not shown so far. RU58841 worked in animals and in scalp tissue, but there is no study of its effect in humans. It has never been approved, and after application it reaches the blood. In sport it is banned as a non-approved substance.
Does biotin help against hair loss?
Only in true biotin deficiency. With normal intake there is no positive controlled trial on hair growth. High amounts of biotin can also distort lab results, which should be mentioned before blood tests.
What side effects does finasteride have?
Sexual dysfunction is known. Since 2025, suicidal thoughts have been confirmed as a side effect of the tablets; their frequency is unknown. Anyone who notices depressed mood on finasteride should stop treatment and seek medical advice.
Information only, not medical advice and no usage or dosage recommendation. Prescription-only and unapproved substances belong in a physician's hands.